Drug intelligence / Profile preview

IVT mRNA RSV

Development stage: Preclinical
Lead developer: Inventprise
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics

Overview

Inventprise is developing IVT mRNA RSV, an mRNA-based vaccine candidate for the prevention of respiratory syncytial virus (RSV) infection and associated acute lower respiratory infections. The vaccine utilizes lipid nanoparticle (LNP) encapsulation to deliver mRNA encoding a specific RSV surface antigen. Upon administration, the mRNA is translated by host cells to produce the viral antigen, thereby inducing a protective immune response. Inventprise has partnered with Quantoom Biosciences to leverage their Ntensify production technology platform for the development of this candidate, which is currently in the preclinical stage.

Other names: mRNA RSV (LNP-encapsulated)respiratory syncytial virus mRNA vaccine

Targets

RSV F (Respiratory syncytial virus fusion protein)

Beyond the preview

Go deeper on IVT mRNA RSV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVT mRNA RSV.

Explore the full profile